Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Crystal Pharmaceutical (Suzhou) Co., Ltd. v. Eisai Inc., No. 23-1017 (Fed. Cir. Sept. 6, 2024)

Affirmed
Rule 36 Affirmance
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 23-1017
Decided
September 6, 2024
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages
Download Opinion (PDF)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

CRYSTAL PHARMACEUTICAL (SUZHOU) CO.,

LTD., BERGEN PHARMACEUTICAL, LLC,

Appellants

v.

EISAI INC.,

Appellee

2023-1017

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. PGR2021-00047.

JUDGMENT

JOHN SCOTT MCBRIDE, Bartlit Beck LLP, Chicago, IL, argued for all appellants. Appellant Bergen Pharmaceutical, LLC also represented by MEG E. FASULO, KATHERINE E. RHOADES; TAYLOR JAMES KELSON, Denver, CO; ADAM MORTARA, Chicago, IL. SCOTT A. CUNNING, II, Parker Poe Adams & Bernstein LLP, Washington, DC, for appellant Crystal Pharmaceutical (Suzhou) Co., Ltd. Also represented by ELIZABETH

2CROMPTON; CECIL KYLE MUSGROVE, Gemini Law LLP, New York, NY. MELANIE R. RUPERT, Paul Hastings LLP, New York, NY, argued for appellee. Also represented by CHRISTOPHER P. HILL, YOUNG J. PARK, BRUCE M. WEXLER; NAVEEN MODI, MICHAEL WOLFE, Washington, DC.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (MOORE, Chief Judge, LINN and PROST,

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

Figure on page 2 of the opinion

September 6, 2024

Date

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Crystal Pharmaceutical (Suzhou) Co., Ltd. v. Eisai Inc., No. 23-1017 (Fed. Cir. Sept. 6, 2024).

Record ID
CAFC-23-1017-20240906
Permalink
https://patentcasewatch.com/opinions/CAFC-23-1017-20240906

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error